We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
VirTra
VTSI
$32.8M
| $3.06K | ﹤0.01% |
398
-118
| -23% | -$1.36K |
|
1877
The RealReal
REAL
$1.15B
| $3.05K | ﹤0.01% |
956
+378
| +65% | +$1.4K |
|
1878
iHeartMedia
IHRT
$408M
| $2.94K | ﹤0.01% |
2,697
-891,002
| -100% | -$1.39M |
|
1879
Harmonic Inc
HLIT
$1.27B
| $2.93K | ﹤0.01% |
+249
| New | +$2.81K |
|
1880
Core Molding Technologies
CMT
$209M
| $2.9K | ﹤0.01% |
182
| – | – |
|
1881
Velocity Financial
VEL
$675M
| $2.83K | ﹤0.01% |
+158
| New | +$2.79K |
|
1882
Cullinan Oncology
CGEM
$1.32B
| $2.81K | ﹤0.01% |
161
-83
| -34% | -$1.77K |
|
|
TBCH
1883
Turtle Beach Corp
TBCH
$225M
| $2.78K | ﹤0.01% |
+194
| New | +$3.02K |
|
1884
iRadimed
IRMD
$1.05B
| $2.77K | ﹤0.01% |
63
-55
| -47% | -$2.34K |
|
1885
Asure Software
ASUR
$245M
| $2.71K | ﹤0.01% |
323
| – | – |
|
|
DM
1886
DELISTED
Desktop Metal, Inc.
DM
| $2.63K | ﹤0.01% |
+636
| New | +$4.35K |
|
1887
Weis Markets
WMK
$1.78B
| $2.38K | ﹤0.01% |
38
| – | – |
|
|
ORAN
1888
DELISTED
Orange
ORAN
| $2.36K | ﹤0.01% |
236
| – | – |
|
1889
Trevi Therapeutics
TRVI
$2.14B
| $2.3K | ﹤0.01% |
773
| – | – |
|
1890
Fossil Group
FOSL
$298M
| $2.28K | ﹤0.01% |
1,583
-2,428
| -61% | -$2.76K |
|
|
SWTX
1891
DELISTED
SpringWorks Therapeutics
SWTX
| $2.26K | ﹤0.01% |
60
-19,681
| -100% | -$828K |
|
1892
Clarivate
CLVT
$1.22B
| $2.25K | ﹤0.01% |
396
| – | – |
|
|
OLP
1893
One Liberty Properties
OLP
$505M
| $2.23K | ﹤0.01% |
+95
| New | +$2.2K |
|
|
NOTV
1894
DELISTED
Inotiv
NOTV
| $2.19K | ﹤0.01% |
1,321
+910
| +221% | +$3.35K |
|
1895
CarParts.com
PRTS
$70M
| $2.18K | ﹤0.01% |
+218
| New | +$2.65K |
|
1896
Hamilton Beach Brands
HBB
$419M
| $2.18K | ﹤0.01% |
127
-51
| -29% | -$1.04K |
|
1897
Coastal Financial
CCB
$716M
| $2.17K | ﹤0.01% |
47
-123
| -72% | -$5.17K |
|
1898
Energy Services of America
ESOA
$208M
| $2.08K | ﹤0.01% |
290
| – | – |
|
|
ARC
1899
DELISTED
ARC Document Solutions, Inc.
ARC
| $2.08K | ﹤0.01% |
786
| – | – |
|
1900
AN2 Therapeutics
ANTX
$202M
| $1.97K | ﹤0.01% |
917
+706
| +335% | +$1.68K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.